Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03625570
Other study ID # R01HD091089
Secondary ID R01HD091089
Status Completed
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date November 10, 2023

Study information

Verified date March 2024
Source Louisiana State University Health Sciences Center in New Orleans
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ambulatory children with cerebral palsy (CP) experience walking limitations which negatively influence their ability to physically participate in day to day life. The investigators propose that impaired muscle power generation is the key limiting factor affecting walking activity and participation. This proposal represents a combined approach where participants undergo resistance training for muscle power generation in combination with locomotor treadmill training that is based on typical pediatric walking and activity patterns rather than adult protocols, which are endurance or time-based. Therefore, the primary objective of this randomized controlled trial is to determine the effect of lower extremity Power Training combined with interval Treadmill Training (PT³) on functional walking capacity and community-based activity and participation in children with CP. We hypothesize that remediating the most pronounced muscle performance impairment (i.e., muscle power) with power training combined with a task- specific approach to walking that is developmentally appropriate will have a significant effect on walking capacity and performance.


Description:

The primary purpose of this randomized controlled trial is to test the effect of Power Training combined with interval Treadmill Training (PT³) on walking capacity and performance in children with CP with walking limitations. To identify key muscular mechanisms associated with improved walking mobility, the effects of PT³ on muscle performance and architecture will be examined. The premise of the PT³ protocol is that a combined impairment and task-specific approach that is developmentally appropriate and targets muscle power deficits specifically, is necessary to drive changes in both clinic and community-based walking activity. In this randomized multi-site clinical trial, 48 ambulatory participants with CP will receive either PT³ or an equivalent dosage of traditional strength training combined with traditional treadmill training (comparison group) for 24 sessions, 3 times per week for 8 weeks. Outcomes will be collected at baseline and immediately post-treatment. Short and long-term retention effects will be assessed at 2 and 6 months post.


Recruitment information / eligibility

Status Completed
Enrollment 43
Est. completion date November 10, 2023
Est. primary completion date October 4, 2023
Accepts healthy volunteers No
Gender All
Age group 10 Years to 17 Years
Eligibility Inclusion Criteria: - Diagnosis of bilateral spastic Cerebral Palsy (CP) - Age 10 to 17 years inclusive - GMFCS levels I, II, or III Exclusion Criteria: - Orthopedic or neurosurgery less than 12 months prior to enrollment - Injection therapies (phenol, botulinum toxin) less than 3 months prior to enrollment - Lacking greater than 25 degrees of knee extension

Study Design


Intervention

Behavioral:
Power training combined with interval treadmill training
Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors according to resistance training guidelines for muscle power training. The interval treadmill training portion will include short-bursts (30 seconds) of high speed walking intervals alternating with 30 seconds of low to moderate speed walking for a total of 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.
Strength training combined with traditional treadmill training
Training will consist of unilateral and bilateral leg presses, targeting the quadriceps, hip extensors, and plantarflexors following the dosing and resistance training guidelines for muscle strength. Traditional treadmill training will consist of walking at steady-state speeds for 30 minutes. Participants will train 3 x per week for 8 weeks. Total duration of each session will be approximately 1 hour.

Locations

Country Name City State
United States Louisiana State University Health Sciences Center New Orleans Louisiana
United States Seattle Children's Hospital Seattle Washington

Sponsors (3)

Lead Sponsor Collaborator
Louisiana State University Health Sciences Center in New Orleans Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Self-selected gait speed Calculated from the 10 meter walk test in meters/second at self-selected speed Baseline and immediate post training
Primary Change in Fast gait speed Calculated from the 10 meter walk test in meters/second at fast walking speed Baseline and immediate post training
Primary Change in Peak power Lower extremity power produced during a power leg press test; product of force x velocity Baseline and immediate post training
Primary Change in Average strides per day Average strides/day as captured by Step Watch accelerometer as worn for 5 days (Community walking activity level) Baseline and immediate post training
Secondary Change in Self-selected gait speed Calculated from the 10 meter walk test in meters/second at self-selected speed Baseline and 2 months and 6 months post training
Secondary Change in Fast gait speed (m/s) Calculated from the 10 meter walk test in meters/second at fast walking speed Baseline and 2 months post training and 6 months post training
Secondary Change in Peak power Lower extremity power produced during a power leg press test; product of force x velocity Baseline and 2 months post training and 6 months post training
Secondary Change in Average strides per day Average strides/day as captured by Step Watch accelerometer as worn for 5 days (Community walking activity level) Baseline and 2 months post training and 6 months post training
Secondary Change in One minute walk test (m) Distance covered while walking as fast as possible for 1 minute measured in meters Baseline and immediate post training, 2 months and 6 months post training
Secondary Change in Cross-sectional area Ultrasound image of cross-sectional area of rectus femoris at 50% distance between anterior superior iliac spine and apex of patella Baseline and immediate post training, 2 months and 6 months post training
Secondary Change in Isokinetic muscle strength Isokinetic dynamometer (Biodex System 3) according to published standard procedures for isokinetic strength. Calculated for knee extensors, ankle plantarflexors. Baseline and immediate post training, 2 months and 6 months post training
Secondary Change in Walking intensity - stride rates (strides/minute) Average strides/day in low (1 to 30 strides/min), medium (31 to 60 stride/min), and high (> 60 stride/min) stride rates as captured by Step Watch accelerometer as worn for 5 days. Baseline and immediate post training, 2 months and 6 months post training
Secondary Change in Patient-Reported Outcomes Measurement Information System (PROMIS v2.0 Pediatric Profile 49 Patient-Reported Outcomes from NINDS Common Data Elements - CP; The PROMIS item bank was developed from patient-reported outcome measures that indicate patients' state of well-being and functional abilities Baseline and immediate post training, 2 months and 6 months post training
Secondary Change in 1RM (muscle strength) 1repetition maximum (1RM) testing on a leg press Baseline and immediate post training, 2 months and 6 months post training
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2